FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects
KFAR SABA, Israel, March 30, 2022 — CartiHeal Ltd, developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced that the U.S. Food and Drug…